None listed
Conditions
Interventions
None listed
Sponsors
The Catholic University of Korea
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Patients with diabetes - Type 2 diabetes - Over 19 years old and 75 years old - HbA1c 7.0% or higher at baseline - Those who have consented to participate in this clinical trial and have given their written consent ? Patients with hypertension - Essential hypertension - Over 19 years old and 75 years old - Mean sitting systolic and diastolic blood pressure at baseline : Mean sitting systolic blood pressure (MSSBP): 140 mmHg or more and less than 180 mmHg : Mean sitting diastolic blood pressure (MSDBP): less than 110 mmHg - Those who have consented to participate in this clinical trial and have given their written consent
Exclusion criteria
Exclusion criteria: ? Patients with diabetes - Receiving insulin pump treatment - Severe renal disease: eGFR<30ml/min - Heart function falls under New Your Heart Association III-IV - Diagnosed with a malignant tumor within the past 5 years and have not completed treatment - Taking systemic steroids or immunosuppressants that affect blood sugar control - Pregnant or lactating - Judged inappropriate to participate in the study due to general weakness, etc. ? Patients with hypertension - Taking 3 or more antihypertensive medications at baseline - History of secondary hypertension or suspected secondary hypertension - Symptomatic orthostatic hypotension - History of cerebral infarction - History of myocardial infarction or unstable angina - Undergone percutaneous coronary intervention (PCI) or coronary artery replacement surgery - Severe heart disease: Heart failure (NYHA grade III ~ IV) - Clinically significant arrhythmia - Cardiomyopathy - Severe kidney or liver disease - Diagnosed with a malignant tumor within the past 5 years and have not completed treatment - Pregnant or lactating - Judged inappropriate to participate in the study due to general weakness, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients with diabetes : Differences in HbA1c change at 1 and 2 years compared to baseline;Patients with hypertension : Differences in SBP change at 1 and 2 years compared to baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients with diabetes : Difference in the rate of reaching less than 7.0% in HbA1c;Patients with diabetes : Difference in the rate of reaching less than 6.5% in HbA1c;Patients with diabetes : Difference in achievement of individualized HbA1c target;Patients with diabetes : Difference in achievement of blood pressure target;Patients with diabetes : Difference in achievement of blood lipid target;Patients with diabetes : The occurrence of new complications after registration;Patients with diabetes : Change assessment of lifestyle;Patients with diabetes : Change assessment of depression and quality of life;Patients with hypertension : Difference in achievement of individualized blood pressure control target;Patients with hypertension : Difference in achievement of fasting plasma glucose target;Patients with hypertension : Difference in achievement of blood lipid target;Patients with hypertension : Differences in change of Na/K levels at 1 and 2 years compared to baseline;Patients with hypertension : The occurrence of new complications after registration;Patients with hypertension : Change assessment of lifestyle;Patients with hypertension : Change assessment of depression and quality of life;Patients with hypertension : Assessment of medication adherence | — |
Countries
Korea, Republic of
Contacts
Public ContactJin-Hee Lee
The Catholic University of Korea
Outcome results
None listed